[1] |
LU Yan, YANG Baorong, HUANG Xiangping, YANG Guangui, CHEN Shengwen, LI Jianrong, ZENG Xiaoming.
MRI-Guided Thrombolysis beyond Time Window in Acute Ischemic Stroke in a County-Level Hospital: A
Case-Control Study
[J]. Chinese Journal of Stroke, 2022, 17(12): 1321-1326.
|
[2] |
WANG Wei, ZHAO Shangfeng, ZHANG Baorui, LIANG Xihong, KANG Jun.
Efficacy of Superselective Intra-arterial Thrombolysis in Treatment of Acute Central Retinal Artery Occlusion
[J]. Chinese Journal of Stroke, 2022, 17(07): 774-779.
|
[3] |
LI Zhenhua, LIU Zhu, HU Quanzhong.
Progress in Drugs Therapy for Non-disabling Ischemic Cerebrovascular Events
[J]. Chinese Journal of Stroke, 2022, 17(04): 407-412.
|
[4] |
HUO Xiaochuan, LI Xiaoqing, MIAO Zhongrong, Expert Committee for Neurointervention Quality Control of National Center for Healthcare Quality Management in Neurological Diseases, Endovascular Treatment Working Committee of National Action for Quality Improvement of Acute Cerebral Infarction Reperfusion Therapy.
A Survey of Current Practice in Acute Ischemic Stroke Endovascular Treatment in China in 2020
[J]. Chinese Journal of Stroke, 2022, 17(01): 56-65.
|
[5] |
CAO Shuangshuang, ZHANG Xiaoyan, WANG Jianwei, ZHAO Lei, CHEN Hongbing, WANG Mingyu.
The Related Factors of Early Neurological Deterioration after Intravenous Thrombolysis in Patients with Acute Ischemic Stroke
[J]. Chinese Journal of Stroke, 2021, 16(12): 1253-1258.
|
[6] |
ZHANG Xin-Miao, WANG Chun-Juan, YANG Xin, GU Hong-Qiu, JIANG Ying-Yu, WANG Yi-Long, ZHAO Xing-Quan, LI Zi-Xiao, WANG Yong-Jun.
Safety of Intravenous Thrombolysis in Acute Ischemic Stroke Patients with Antithrombotic Therapy before Stroke Onset
[J]. Chinese Journal of Stroke, 2021, 16(11): 1110-1114.
|
[7] |
WANG Cong-Jie, LI Hong, ZHENG Li, LIU Shan, LU Hai-Li, CHEN Na, ZHANG Bin, ZHOU Heng.
Efficacy of Dual Antiplatelet Therapy after Intravenous Thrombolysis in Patients with Mild Ischemic Stroke
[J]. Chinese Journal of Stroke, 2021, 16(10): 1044-1049.
|
[8] |
ZHANG Xue-Lei, MIAO Zhong-Rong, LIU Wei.
Efficacy and Safety of Endovascular Therapy for Acute Ischemic Stroke Patients with Large Infarct Core
[J]. Chinese Journal of Stroke, 2021, 16(09): 901-908.
|
[9] |
YU Feng-Chun, QI Yan-Yan, ZHANG Jing, GAO Bing, WANG Xue-Hong, ZHAO Feng-Li, WANG Su-Li, FANG Zhi-Yong, QIAO Shu-Dong, BI Qi.
Safety and Efficacy of 50 mg Enteric Sustained-Release Aspirin Tablet in Secondary Prevention of Mild Ischemic#br#
Stroke/Transient Ischemic Attack#br#
[J]. Chinese Journal of Stroke, 2021, 16(07): 657-663.
|
[10] |
WANG Zhen, XU Wei, HE Guo-Hua, HU Jue, FENG Tie-Qiao, TONG Yang-Ping, XU Gui-Lan, XIAO Hui, YI Hai-Bo, SONG Zhi.
Clinical Features and Prognosis of Remote Parenchymal Hemorrhage after Intravenous Thrombolysis in Acute Ischemic Stroke
[J]. Chinese Journal of Stroke, 2021, 16(07): 680-686.
|
[11] |
CHEN Ying, GAO Ya-Li, LIN Fang-Ju, JIA Wei-Hua.
Clinical Analysis and Literature Review of Intravenous Thrombolysis in Acute Ischemic Stroke with Active Malignancy
[J]. Chinese Journal of Stroke, 2021, 16(02): 130-135.
|
[12] |
HUANG Li-Hong, LIU Guang-Wei.
A Review on Risk Factors Associated with Poor Prognosis after Intravenous Thrombolysis in Ischemic Stroke Patients
[J]. Chinese Journal of Stroke, 2020, 15(12): 1352-1359.
|
[13] |
LIU Hui-Hui, JIANG Qian-Mei, DAI Jing,LIU Chun-Feng.
Advances in Intravenous Thrombolysis for Acute Ischemic Stroke
[J]. Chinese Journal of Stroke, 2020, 15(09): 934-941.
|
[14] |
WU Ya, LI Wei.
Status of Intravenous Thrombolysis for Acute Perforating Artery Infarcts
[J]. Chinese Journal of Stroke, 2020, 15(09): 942-946.
|
[15] |
MA Can-Can, ZHANG Xi-Bin, LI Xiao-Bo, CHEN Bei-Lei, LI Jun, JING Jian.
Efficacy and Safety of Alteplase Intravenous Thrombolysis in Elderly Patients with Acute Cerebral Infarction
[J]. Chinese Journal of Stroke, 2020, 15(09): 972-977.
|